The Herbal Sleep Aid Supplement Market size is expected to reach $4.51 billion in 2030 at a CAGR of 7.2%, driven by rising stress and anxiety levels.
Read More
The Herbal Medicine Market size is expected to reach $391.88 billion in 2030 at a CAGR of 11.1%, driven by pharma use of herbal products.
Read More
The HER2 Inhibitors Market size is expected to reach $14.85 billion in 2030 at a CAGR of 8.8%, driven by government breast cancer initiatives.
Read More
The Hepatorenal Syndrome Treatment Market size is expected to reach $21.12 billion in 2030 at a CAGR of 7.0%, driven by fast-track drug approvals.
Read More
The Hepatocellular Carcinoma Drugs Market size is expected to reach $1.89 billion in 2030 at a CAGR of 8.8%, driven by rising HCC cases.
Read More
The Hepatitis Therapeutics Market size is expected to reach $23.43 billion in 2030 at a CAGR of 4.3%, driven by growing clinical trials.
Read More
The global Hepatitis Drugs Market size is expected to reach $25.09 billion in 2030 at a CAGR of 3.8%, driven by rising R&D investment.
Read More
The Hepatitis B Virus (HBV) Capsid Inhibitors market size is expected to reach $0.98 billion in 2030 at a CAGR of 13.4%, driven by rising HBV infections.
Read More
The Hepatitis B Virus (HBV) market size is expected to reach $11.77 billion in 2030 at a CAGR of 10.2%, driven by high HBV prevalence.
Read More
The global Heparin market size is expected to reach $14.67 billion in 2030 at a CAGR of 7.5%, driven by rising surgical procedures.
Read More